Toxicological assessment of Pleurotus ostreatus in Sprague Dawley rats

Author(s):  
Krishnamoorthy Deepalakshmi ◽  
Sankaran Mirunalini
2020 ◽  
Vol 1665 ◽  
pp. 012035
Author(s):  
Ema Pristi Yunita ◽  
Astilia Mildha Yuniar ◽  
Inggita Kusumastuty ◽  
Alma Maghfirotun ◽  
Dian Handayani

2013 ◽  
Vol 32 (5) ◽  
pp. 385-394 ◽  
Author(s):  
Antoinette Y. Odendaal ◽  
Narendra S. Deshmukh ◽  
Tennille K. Marx ◽  
Alexander G. Schauss ◽  
John R. Endres ◽  
...  

This toxicological assessment evaluated the safety of a hydroethanolic extract prepared from Caralluma fimbriata (CFE), a dietary supplement marketed worldwide as an appetite suppressant. Studies included 2 in vitro genotoxicity assays, a repeated dose oral toxicity study, and a developmental study in rats. No evidence of in vitro mutagenicity or clastogenicity surfaced in the in vitro studies at concentrations up to 5000 μg of extract/plate (Ames test) or 5000 μg of extract/mL (chromosomal aberration test). No deaths or treatment-related toxicity were seen in the 6-month chronic oral toxicity study in Sprague-Dawley rats conducted at 3 doses (100, 300, and 1000 mg/kg body weight (bw)/d). The no observed effect level for CFE in this study was considered to be 1000 mg/kg bw/d. A prenatal developmental toxicity study conducted at 3 doses (250, 500, and 1000 mg/kg bw/d) in female Sprague-Dawley rats resulted in no treatment-related external, visceral, or skeletal fetal abnormalities, and no treatment-related maternal or pregnancy alterations were seen at and up to the maximum dose tested. CFE was not associated with any toxicity or adverse events.


2011 ◽  
Vol 49 (2) ◽  
pp. 429-433 ◽  
Author(s):  
Tai-I Chen ◽  
Chin-Chu Chen ◽  
Ting-Wei Lin ◽  
Yueh-Ting Tsai ◽  
Mun-Kit Nam

2017 ◽  
Vol 280 ◽  
pp. S144
Author(s):  
Blaine Phillips ◽  
Jenny Ho ◽  
Davide Sciuscio ◽  
Emilija Veljkovic ◽  
Stefan Lebrun ◽  
...  

2012 ◽  
Vol 50 (5) ◽  
pp. 1279-1287 ◽  
Author(s):  
Tingting Xu ◽  
Shuai Zhang ◽  
Lingli Zheng ◽  
Lianhong Yin ◽  
Lina Xu ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-12
Author(s):  
Donatus Wewura Adongo ◽  
Priscilla Kolibea Mante ◽  
Kennedy Kwami Edem Kukuia ◽  
Charles Kwaku Benneh ◽  
Robert Peter Biney ◽  
...  

Pseudospondias microcarpa is used traditionally for treating various diseases. However, although parts of the plant are extensively used in African traditional medicine, no scientific study has been reported on its toxicity. Therefore, this study evaluated the acute and subacute toxicity studies of the ethanolic extract of P. microcarpa in rats. Male Sprague-Dawley rats (120–150 g) were treated orally with the extract (30, 100, 300, 1000, and 3000 mg kg−1) or distilled water (10 ml kg−1) for 2 weeks and observed daily for general appearance and signs of toxicity. In addition, blood was collected for both biochemical and haematological assays. Sections of tissues from liver, kidney, spleen, brain, and stomach were also used for histopathological examination. Administration of the extract for 14 consecutive days caused no deaths, with an LD50 above 3000 mg kg−1. Except for lymphocytes (%) that showed a significant decrease (F5,23=3.93, P=0.013), all other haematological parameters remained unaffected by the extract. The extract at 100 mg kg−1 showed a significant decrease in the levels of triglyceride and very-low-density lipoproteins (both at P<0.05). Weight change as well as histological evaluation of the organs indicated no toxicity. The study demonstrates that an ethanolic extract of P. microcarpa given orally to rats is safe.


Sign in / Sign up

Export Citation Format

Share Document